
European journal of psychotraumatology (PubMed)··Research ArticlePractice applicable
Mental-health nurses often care for young people whose trauma symptoms and substance use interact, complicating engagement and treatment planning. The trial supports coordinated treatment rather than requiring PTSD work to wait for substance-use remission, while leaving exposure therapy to appropriately trained clinicians.
PsychPedsAt four months, COPE-A produced a 9.82-point greater reduction in PTSD symptom severity and lower odds of meeting PTSD diagnostic criteria than the comparison therapy; improvements were maintained through 12 months. Both groups reduced substance use and disorder severity over time, with no significant between-group difference. Participants reported greater satisfaction with COPE-A, and no study-related adverse events were reported.
Key takeaways
- The trial randomized 55 adolescents and young adults age 12 to 25 to COPE-A or person-centered supportive therapy.
- COPE-A produced a greater reduction in PTSD symptoms by the four-month primary endpoint.
- Substance-use outcomes improved over time in both groups without a significant between-group difference.
- The small single-region trial reported no study-related adverse events but cannot establish safety or effectiveness across all youth settings.
Why this matters on shift
Mental-health nurses often care for young people whose trauma symptoms and substance use interact, complicating engagement and treatment planning. The trial supports coordinated treatment rather than requiring PTSD work to wait for substance-use remission, while leaving exposure therapy to appropriately trained clinicians.
Bedside takeaway
Integrated therapy accelerated PTSD improvement, while substance-use outcomes were similar and treatment still requires trained clinical oversight.
Nursing implications
- Assess and document trauma symptoms, substance use, acute risk, engagement barriers, and treatment goals without framing one condition as a reason to ignore the other. Support attendance and coping plans, monitor response and safety, and communicate changes to the clinician delivering the integrated therapy.
Limitations & cautions
- The trial enrolled 55 participants in Sydney, most of whom were female, and compared two active psychotherapies. The small sample limits subgroup and uncommon-harm assessment, substance-use outcomes did not differ between groups, and results may not generalize to other ages, settings, treatment models, or levels of acuity.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations · exact source links
Explain this for my unit
AI-summarized from the linked source. Review the original article before applying to practice.
















